Latanoprostene Bunod

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLatanoprostene Bunod
Drug Alias Namelatanoprosteno bunod拉坦前列烯酯latanoprostenum bunodum布诺-拉坦前列烯Vyzulta +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid FP receptor agonistsNitric oxide donors
TargetsProstanoid FP receptor
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleOcular Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/11/02
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer IncNicox
China Registration ClassN/A

Develop Information

Active CompaniesBausch & Lomb
Inactive CompaniesBausch & Lomb Incorporated
Active IndicationsGlaucoma, Open-AngleOcular Hypertension
Inactive IndicationsGlaucoma

Other Information

ATC CodeS01EE06
Related LinksDrugBankKEGG